Advertisement

Topics

Scancell adds six ‘world-leading’ cancer specialists to advisory board ahead of Modi-1 trial

03:45 EDT 10 May 2019 | Proactive Investors

“The initial focus of the board will be to inform the clinical strategy for the planned Modi-1 clinical trial and to ensure the best possible outcome in several solid tumour indications”

Original Article: Scancell adds six ‘world-leading’ cancer specialists to advisory board ahead of Modi-1 trial

NEXT ARTICLE

More From BioPortfolio on "Scancell adds six ‘world-leading’ cancer specialists to advisory board ahead of Modi-1 trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...